Tyra Biosciences Inc. (TYRA)
NASDAQ: TYRA
· Real-Time Price · USD
10.73
0.03 (0.28%)
At close: Aug 15, 2025, 3:59 PM
10.73
0.00%
After-hours: Aug 15, 2025, 04:34 PM EDT
Tyra Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -28.15M | -25.57M | -24.02M | -18.7M | -18.19M | -22.83M | -21.15M | -13.27M | -11.88M | -12.89M | -12.51M | -15.1M | -14.83M | -9.93M | -6.64M | -5.51M | -4.21M |
Depreciation & Amortization | 143K | 144K | 127K | 126K | 122K | 102K | 82K | 86K | 83K | 82K | 82K | 68K | 64K | 50K | 41K | 27K | 22K |
Stock-Based Compensation | 6.42M | 6.7M | 7.57M | 4.41M | 4.12M | 4.19M | 4.38M | 2.53M | 2.43M | 2.91M | 1.02M | 2.69M | 3.97M | 1.87M | 507K | 338K | 174K |
Other Working Capital | -3.01M | 318K | 1.07M | 5.77M | -6.84M | 6.26M | -453K | 1.04M | -483K | -2.28M | -853K | -5.37M | 303K | -1.11M | -711K | -59K | -91K |
Other Non-Cash Items | -866K | -1.18M | -2.65M | 2.8M | 3.13M | 3.14M | 1K | 3K | n/a | -5.85M | 1K | 2.83M | 2K | -483K | 3K | 392K | 218K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -4.39M | n/a | n/a | n/a | 5.85M | n/a | -2.83M | n/a | 483K | n/a | n/a | n/a |
Change in Working Capital | -3.01M | 318K | 1.07M | 5.77M | -6.84M | 6.26M | -453K | 1.04M | -483K | -2.08M | -805K | -4.83M | 1.86M | -1.02M | 514K | 686K | -665K |
Operating Cash Flow | -25.46M | -19.59M | -17.9M | -10.26M | -22.03M | -13.53M | -17.14M | -9.62M | -9.85M | -11.98M | -12.21M | -17.17M | -8.93M | -9.03M | -5.58M | -4.46M | -4.68M |
Capital Expenditures | -14K | -6K | -52K | -470K | -136K | -603K | -83K | -43K | -41K | -21K | -48K | -251K | -239K | -105K | -256K | -240K | -60K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16K | n/a | n/a |
Purchase of Investments | -6.87M | -38.04M | -36.39M | -177.41M | -11.79M | -143.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 38.91M | 45M | 58M | 32.88M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -144.52K | 18.21K | -143.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16K | n/a | n/a |
Investing Cash Flow | 32.03M | 6.96M | 21.56M | -144.99M | 18.07M | -144.44M | -83K | -43K | -41K | -21K | -48K | -251K | -239K | -105K | -240K | -240K | -60K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -4K |
Common Stock Repurchased | n/a | n/a | 420K | -251K | -169K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -23K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.19M | 706K | 743K | 373K | 484K | 324K | 467K | 370K | 376K | 3K | n/a | n/a | n/a | n/a | 183.46M | -731K | 130.16M |
Financial Cash Flow | 2.19M | 706K | 743K | 373K | 200.31M | 324K | 467K | 370K | 376K | 3.00 | 364.00 | 27.00 | 238.00 | -1.51M | 183.44M | -733K | 130.15M |
Net Cash Flow | 8.76M | -11.93M | 4.4M | -154.88M | 196.36M | -157.65M | -16.76M | -9.29M | -9.51M | -12M | -11.9M | -17.39M | -8.93M | -10.64M | 177.62M | -5.43M | 125.41M |
Free Cash Flow | -25.47M | -19.6M | -17.95M | -10.73M | -22.16M | -14.13M | -17.23M | -9.66M | -9.89M | -12M | -12.26M | -17.42M | -9.16M | -9.13M | -5.83M | -4.7M | -4.74M |